MannKind Corporation to Hold 2020 Second Quarter Financial Results Conference Call on August 5, 2020
MannKind Corporation (NASDAQ: MNKD) will announce its 2020 second quarter financial results and provide corporate updates during a conference call scheduled for August 5, 2020, at 5:00 PM ET. The call will feature CEO Michael Castagna and CFO Steven Binder. Interested parties can access the live call via the company's website, with a playback option available for 14 days post-call.
MannKind is focused on developing inhaled therapies for diabetes and orphan lung diseases, highlighting its commercial product, Afrezza®.
- MannKind is commercializing Afrezza®, the only inhaled ultra-rapid-acting mealtime insulin in the U.S.
- None.
WESTLAKE VILLAGE, Calif., July 29, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) will release its 2020 second quarter financial results and its management will host a conference call to discuss the financial results and corporate updates at 5:00 PM (Eastern Time) on Wednesday, August 5, 2020.
Presenting from the Company will be its Chief Executive Officer, Michael Castagna and Chief Financial Officer, Steven Binder.
Those interested in listening to the conference call live via the Internet may do so by visiting the Company's website at http://www.mannkindcorp.com under News & Events.
A telephone replay of the call will be accessible for approximately 14 days following completion of the call by dialing (844) 512-2921 or (412) 317-6671 and use the participant passcode: 7888638#. A replay will also be available on MannKind's website for 14 days.
About MannKind Corporation
MannKind Corporation (NASDAQ: MNKD) focuses on the development and commercialization of inhaled therapeutic products for patients with diabetes and orphan lung diseases. MannKind is currently commercializing Afrezza® (insulin human) Inhalation Powder, the Company’s first FDA-approved product and the only inhaled ultra rapid-acting mealtime insulin in the United States, where it is available by prescription from pharmacies nationwide. MannKind is headquartered in Westlake Village, California, and has a state-of-the art manufacturing facility in Danbury, Connecticut. The Company also employs field sales and medical representatives across the U.S. For further information, visit www.mannkindcorp.com.
Company Contact:
Phone: (818) 661-5000
Email: ir@mannkindcorp.com
FAQ
What are MannKind's second quarter financial results for 2020?
Who is presenting MannKind's financial results?
How can I listen to MannKind's conference call?
What is Afrezza®?
